ClinicalTrials.Veeva

Menu
C

Clinresco Centres | Kempton Park, South Africa

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Levofloxacin
Lanifibranor
Ritlecitinib
LY3009104
Baricitinib
LY4268989
Eravacycline

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Active, not recruiting
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337
Locations recently updated

The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderatel...

Enrolling
Ulcerative Colitis (UC)
Ulcerative Colitis, Active Severe
Drug: Placebo
Drug: LY4268989

Trial sponsors

Lilly logo
Pfizer logo
BioNTech logo
I
P
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems